Effect of Glucagon-like Peptide-1 on the Differentiation of Adipose-derived Stem Cells into Osteoblasts and Adipocytes

키워드

참고문헌 (38)

1. Schwartz AV., "TZDs and Bone : A Review of the Recent Clinical Evidence", PPAR Res, 2008, pp.297893~ (2008)
2. Schwartz AV., "Thiazolidinedione use and bone loss in older diabetic adults", J Clin Endocrinol Metab, 91, pp.3349~3354 (2006)
3. Duque G., "Bone and fat connection in aging bone", Curr Opin Rheumatol, 20, pp.429~434 (2008)
4. Barnett A., "DPP-4 inhibitors and their potential role in the management of type 2 diabetes", Int J Clin Pract, 60, pp.1454~1470 (2006)
5. Creutzfeldt W., "The entero-insular axis in type 2 diabetes--incretins as therapeutic agents", Exp Clin Endocrinol Diabetes, 109(Suppl 2), pp.S288~S303 (2001)
6. Holst JJ., "The physiology of glucagon-like peptide 1", Physiol Rev, 87, pp.1409~1439 (2007)
7. Ma X., "Poly-GLP-1, a novel long-lasting glucagon-like peptide-1 polymer, ameliorates hyperglycaemia by improving insulin sensitivity and increasing pancreatic beta-cell proliferation", Diabetes Obes Metab, 11, pp.953~965 (2009)
8. Alvarez E., "The expression of GLP-1 receptor mRNA and protein allows the effect of GLP-1 on glucose metabolism in the human hypothalamus and brainstem", J Neurochem, 92, pp.798~806 (2005)
9. Alvarez E., "Expression of the glucagon-like peptide-1 receptor gene in rat brain", J Neurochem, 66, pp.920~927 (1996)
10. Nikolaidis LA., "Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion", Circulation, 109, pp.962~965 (2004)
11. Gutniak M., "Antidiabetogenic effect of glucagon-like peptide-1(7-36)amide in normal subjects and patients with diabetes mellitus", N Engl J Med, 326, pp.1316~1322 (1992)
12. Toft-Nielsen MB., "Determinants of the effectiveness of glucagon-like peptide-1 in type 2 diabetes", J Clin Endocrinol Metab, 86, pp.3853~3860 (2001)
13. Singh S., "Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus : a population-based matched case-control study", JAMA Intern Med, 173, pp.534~539 (2013)
14. Sanz C., "Signaling and biological effects of glucagonlike peptide 1 on the differentiation of mesenchymal stem cells from human bone marrow", Am J Physiol Endocrinol Metab, 298, pp.E634~E643 (2010)
15. Yamada C., "The murine glucagon-like peptide-1 receptor is essential for control of bone resorption", Endocrinology, 149, pp.574~579 (2008)
16. Nuche-Berenguer B., "GLP-1 and exendin-4 can reverse hyperlipidic-related osteopenia", J Endocrinol, 209, pp.203~210 (2011)
17. Pittenger MF., "Multilineage potential of adult human mesenchymal stem cells", Science, 284, pp.143~147 (1999)
18. Wagers AJ., "Plasticity of adult stem cells", Cell, 116, pp.639~648 (2004)
19. Cowan CM., "Adipose-derived adult stromal cells heal criticalsize mouse calvarial defects", Nat Biotechnol, 22, pp.560~567 (2004)
20. Zuk PA., "Human adipose tissue is a source of multipotent stem cells", Mol Biol Cell, 13, pp.4279~4295 (2002)
21. Beresford JN., "Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures", J Cell Sci, 102(Pt 2), pp.341~351 (1992)
22. Hong JH., "TAZ : a beta-catenin-like molecule that regulates mesenchymal stem cell differentiation", Cell Cycle, 5, pp.176~179 (2006)
23. Lee BI., "Hormone replacement therapy following stem cell transplant", J Korean Soc Menopause, 13, pp.8~13 (2007)
24. Nuche-Berenguer B., "Effect of GLP-1 treatment on bone turnover in normal, type 2 diabetic, and insulin-resistant states", Calcif Tissue Int, 84, pp.453~461 (2009)
25. Quoyer J., "GLP-1 mediates antiapoptotic effect by phosphorylating Bad through a beta-arrestin 1-mediated ERK1", 2 activation in pancreatic beta-cells, 2010, pp.285, 1989~2002
26. Nuche-Berenguer B., "Presence of a functional receptor for GLP-1 in osteoblastic cells, independent of the cAMP-linked GLP-1 receptor", J Cell Physiol, 225, pp.585~592 (2010)
27. Pacheco-Pantoja EL., "Receptors and effects of gut hormones in three osteoblastic cell lines", BMC Physiol, 11, pp.12~ (2011)
28. Challa TD., "Regulation of adipocyte formation by GLP-1", GLP-1R signaling, 2012, pp.287, 6421~6430
29. Aubin JE., "Osteoblast and chondroblast differentiation", Bone, 17, pp.77S~83S (1995)
30. Golub EE., "The role of alkaline phosphatase in mineralization", Curr Opin Orthop, 18, pp.444~448 (2007)
31. 안기훈, "Barium Stimulates the Expression of Osteogenic Genes in Human Mesenchymal Stem Cells into Osteoblasts in vitro", 대한폐경학회지, 17(2), pp.81~87 (2011), 대한폐경학회[DOI]
32. Yang J., "Glucagon-like peptide 1 regulates adipogenesis in 3T3-L1 preadipocytes", Int J Mol Med, 31, pp.1429~1435 (2013)
33. Meunier P., "Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies", Clin Orthop Relat Res, 80, pp.147~154 (1971)
34. Moerman EJ., "Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma", stem cells : the role of PPAR-gamma2 transcription factor and TGF-beta, Aging Cell, pp.2004, 3[DOI]
35. Akune T., "PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors", J Clin Invest, 113, pp.846~855 (2004)
36. Justesen J., "Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis", Biogerontology, 2, pp.165~171 (2001)
37. Choi SS., "Honokiol enhances adipocyte differentiation by potentiating insulin signaling in 3T3-L1 preadipocytes", J Nat Med, 65, pp.424~430 (2011)
38. Zhang M., "Genistein suppresses adipogenesis of 3T3-L1 cells via multiple signal pathways", Phytother Res, 23, pp.713~718 (2009)

관련 논문AI추천